IN2014MN00191A - - Google Patents

Info

Publication number
IN2014MN00191A
IN2014MN00191A IN191MUN2014A IN2014MN00191A IN 2014MN00191 A IN2014MN00191 A IN 2014MN00191A IN 191MUN2014 A IN191MUN2014 A IN 191MUN2014A IN 2014MN00191 A IN2014MN00191 A IN 2014MN00191A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Chafiq Hamdouchi
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46690732&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014MN00191(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IN2014MN00191A publication Critical patent/IN2014MN00191A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN191MUN2014 2011-08-17 2014-01-30 IN2014MN00191A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161524462P 2011-08-17 2011-08-17
PCT/US2012/050051 WO2013025424A1 (en) 2011-08-17 2012-08-09 A Novel 1,2,3,4-Tetrahydroquinoline Derivative Useful for the Treatment of Diabetes

Publications (1)

Publication Number Publication Date
IN2014MN00191A true IN2014MN00191A (ru) 2015-08-21

Family

ID=46690732

Family Applications (1)

Application Number Title Priority Date Filing Date
IN191MUN2014 IN2014MN00191A (ru) 2011-08-17 2014-01-30

Country Status (29)

Country Link
US (1) US8431706B2 (ru)
EP (1) EP2744806B1 (ru)
JP (1) JP5903162B2 (ru)
KR (1) KR101570624B1 (ru)
CN (1) CN103687856B (ru)
AP (1) AP3589A (ru)
AR (1) AR087451A1 (ru)
AU (1) AU2012295372A1 (ru)
BR (1) BR112014003079A2 (ru)
CA (1) CA2843474C (ru)
CL (1) CL2014000357A1 (ru)
CO (1) CO6880069A2 (ru)
CR (1) CR20140052A (ru)
DO (1) DOP2014000018A (ru)
EA (1) EA022165B1 (ru)
EC (1) ECSP14013211A (ru)
ES (1) ES2578165T3 (ru)
GT (1) GT201400022A (ru)
IL (1) IL230635A (ru)
IN (1) IN2014MN00191A (ru)
MA (1) MA35351B1 (ru)
MX (1) MX2014001832A (ru)
PE (1) PE20140831A1 (ru)
SG (1) SG11201401793PA (ru)
TN (1) TN2014000058A1 (ru)
TW (1) TWI537262B (ru)
UA (1) UA110983C2 (ru)
WO (1) WO2013025424A1 (ru)
ZA (1) ZA201400705B (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201690888A1 (ru) 2013-11-14 2016-10-31 Кадила Хелзкэр Лимитед Новые гетероциклические соединения
EP3076959B1 (en) 2013-12-04 2018-07-04 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
EP3102198B1 (en) 2014-02-06 2020-08-26 Merck Sharp & Dohme Corp. Antidiabetic compounds
CN109666027A (zh) * 2017-10-17 2019-04-23 中国科学院上海药物研究所 一类酰胺结构的gpr40激动剂化合物及其用途
PT3737470T (pt) 2018-01-08 2023-03-02 Celon Pharma Sa Derivados do ácido 3-fenil-4-hexinoico como agonistas de gpr40
PE20210640A1 (es) 2018-02-13 2021-03-23 Gilead Sciences Inc Inhibidores pd-1/pd-l1
TWI712412B (zh) 2018-04-19 2020-12-11 美商基利科學股份有限公司 Pd‐1/pd‐l1抑制劑
ES2962674T3 (es) 2018-07-13 2024-03-20 Gilead Sciences Inc Inhibidores PD-1/PD-L1
CN112955435B (zh) 2018-10-24 2024-09-06 吉利德科学公司 Pd-1/pd-l1抑制剂
TWI751585B (zh) * 2019-06-28 2022-01-01 美商美國禮來大藥廠 類升糖素肽1受體促效劑
AU2020363377A1 (en) 2019-10-07 2022-04-21 Kallyope, Inc. GPR119 agonists
JP2022554292A (ja) * 2019-10-31 2022-12-28 中国石油化工股▲ふん▼有限公司 担持触媒、その調製方法およびその適用
CA3178994A1 (en) 2020-05-19 2021-11-25 Iyassu Sebhat Ampk activators
AU2021297323A1 (en) 2020-06-26 2023-02-16 Kallyope, Inc. AMPK activators
KR102699076B1 (ko) * 2021-04-01 2024-08-27 현대약품 주식회사 3-(4-(벤질옥시)페닐)헥스-4-이노익산 유도체의 신규 용도
CN115317484B (zh) * 2022-08-26 2023-07-18 北京箭牧科技有限公司 Ly2922470在制备预防或治疗脑血管疾病或组织缺血再灌注损伤药物中的应用
CN115671105B (zh) * 2022-11-22 2023-10-27 北京箭牧科技有限公司 Ly2922470在制备预防或治疗肾脏疾病药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT199900147A (es) * 1998-09-17 1999-09-06 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
US6197786B1 (en) * 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
KR20040016844A (ko) * 2001-03-27 2004-02-25 액테리온 파마슈티칼 리미티드 유로텐신 ⅱ 수용체 길항제인1,2,3,4-테트라하이드로이소퀴놀린 유도체
EP1737809B1 (en) * 2004-02-27 2013-09-18 Amgen, Inc Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
US7786165B2 (en) * 2004-03-15 2010-08-31 Takeda Pharmaceutical Company Limited Aminophenylpropanoic acid derivative
JP4859665B2 (ja) * 2004-03-30 2012-01-25 武田薬品工業株式会社 アルコキシフェニルプロパン酸誘導体
AR078522A1 (es) 2009-10-15 2011-11-16 Lilly Co Eli Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis
AR078948A1 (es) 2009-11-30 2011-12-14 Lilly Co Eli Compuestos de espiropiperidina, composicion farmaceutica que lo comprenden y su uso para preparar un medicamento util para tratar la diabetes

Also Published As

Publication number Publication date
KR101570624B1 (ko) 2015-11-19
CR20140052A (es) 2014-06-20
GT201400022A (es) 2015-01-16
AR087451A1 (es) 2014-03-26
WO2013025424A1 (en) 2013-02-21
CL2014000357A1 (es) 2014-09-05
UA110983C2 (ru) 2016-03-10
TWI537262B (zh) 2016-06-11
AU2012295372A1 (en) 2014-01-23
SG11201401793PA (en) 2014-09-26
MX2014001832A (es) 2014-02-27
PE20140831A1 (es) 2014-07-14
US20130045990A1 (en) 2013-02-21
JP2014521744A (ja) 2014-08-28
ECSP14013211A (es) 2014-03-31
ZA201400705B (en) 2015-11-25
CN103687856B (zh) 2015-07-22
CN103687856A (zh) 2014-03-26
TW201319060A (zh) 2013-05-16
EA201490269A1 (ru) 2014-05-30
IL230635A (en) 2015-11-30
DOP2014000018A (es) 2014-04-15
ES2578165T3 (es) 2016-07-21
EP2744806A1 (en) 2014-06-25
BR112014003079A2 (pt) 2017-02-21
TN2014000058A1 (en) 2015-07-01
AP3589A (en) 2016-02-15
MA35351B1 (fr) 2014-08-01
CO6880069A2 (es) 2014-02-28
AP2014007436A0 (en) 2014-02-28
IL230635A0 (en) 2014-03-31
EA022165B1 (ru) 2015-11-30
NZ621248A (en) 2015-08-28
US8431706B2 (en) 2013-04-30
CA2843474C (en) 2015-12-15
KR20140041835A (ko) 2014-04-04
CA2843474A1 (en) 2013-02-21
EP2744806B1 (en) 2016-04-27
JP5903162B2 (ja) 2016-04-13

Similar Documents

Publication Publication Date Title
BR112013022641A2 (ru)
BR112013024383A2 (ru)
BR112013026905A2 (ru)
BR112013023185A2 (ru)
BR112013022995A2 (ru)
BR112013026744A2 (ru)
BR112013017670A2 (ru)
BR112013023927A2 (ru)
BR112013024365A2 (ru)
BR112013027121A2 (ru)
AP2016009466A0 (ru)
BR112013031556A2 (ru)
BR112013024588A2 (ru)
BR112013026790A2 (ru)
BR112013032377A2 (ru)
BR112013032380A2 (ru)
BR112013032368A2 (ru)
BR112013026895A2 (ru)
IN2014MN00191A (ru)
BR112013018949A2 (ru)
BR112013027836A2 (ru)
BR112013021637A2 (ru)
BR112013023266A2 (ru)
BR112013032392A2 (ru)
BR112013025487A2 (ru)